23andMe Valuation Decline

Order byBest matchMost fresh

23andMe Found a Buyer for Our Genetic Data

23andMe sale reveals what your genetic data is worth. It’s less than you think

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK made a $300 million dollar deal with 23andMe which allowed it to acquire the genetic data of 5 million people. That means the value of each customer’s data was about $60 at that time.

Observer · 19h

23andMe Has Found a Buyer—Here’s What Might Happen to Your Genetic Data

· 1d · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

· 1d

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

· 2d

Regeneron agrees to buy bankrupt 23andMe

· 2d

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Hip-Hop Wired19h

DNA Giant 23andMe To Be Acquired After Bankruptcy

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, Medtronic’s diabetes spinoff, Regeneron’s purchase of 23AndMe, and more.

Yahoo Finance10d

23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14

23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file ...

Fast Company8d

23andMe update: Customers have a new deadline to file data breach claims amid Chapter 11 bankruptcy. Here’s how to do it

Some important news for millions of 23andMe customers: The genetic testing company notified customers on Sunday that they now have until July 14 to file potential claims as the company navigates ...

Reuters29d

23andMe bankruptcy sale may need national security review

April 22 (Reuters) - Bankrupt genetic test company 23andMe may face opposition from the U.S. government if it tries to sell itself to a foreign buyer, according to a Tuesday court filing by ...

Biotechnology firm buying DNA testing company out of bankruptcy in $256 million deal

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.